<DOC>
	<DOCNO>NCT02439944</DOCNO>
	<brief_summary>This study involve use personalize nicotine patch dose treatment strategy smoker quit smoke 2 week use standard nicotine patch dose . Functional Magnetic Resonance Imaging scan also obtain study participant treatment . The first aim study determine treatment method investigation safe effective increase quit rate smoker respond standard therapy.The second aim determine treatment- cessation-related change brain function .</brief_summary>
	<brief_title>Efficacy Neural Correlates Personalized Treatment With Transdermal Nicotine Replacement</brief_title>
	<detailed_description>Nicotine Replacement Therapy ( NRT ) limit efficacy . One possible explanation limit efficacy nicotine dose receive standard therapy enough replace amount nicotine smoker typically receive cigarette . In effort counteract problem , study increase nicotine patch dose smoker longer feel need keep smoke tolerate high nicotine dose . Smokers quit use 21 mg nicotine patch 2 week randomize either experimental arm study nicotine patch dos adjust accord individual need positive control arm standard NRT smoking cessation therapy employ . The primary outcome measure continuous abstinence last 4 week treatment . In addition , participant assess see treatment impact rest state neural activity well responsiveness smoke emotional cue . Follow session use assess long term abstinence well long term change neural activation .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Daily tobacco smoker Aged 19 65 year old Intending quit smoking within next 30 day Interested use transdermal nicotine replacement therapy ( nicotine patch ) At least weekly use tobacco product cigarettes Breast feeding , pregnancy use reliable form birth control Any generalize skin disorder preclude use patch Immediate postmyocardial infarction period lifethreatening arrhythmia , severe worsen angina pectoris recent cerebral vascular accident Any clinically significant electrocardiogram ( ECG ) abnormalities Currently use NRT smoke cessation pharmacotherapy Any known hypersensitivity allergy component comprise nicotine patch MRI contraindication ( e.g. , metal body , claustrophobia ) per CAMH RIC screen questionnaire Diagnosis terminal illness .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Nicotine Patch</keyword>
	<keyword>Nicotine Mouth Spray</keyword>
	<keyword>Smoking Cessation</keyword>
	<keyword>Quit Smoking</keyword>
	<keyword>Abstinence</keyword>
	<keyword>Dependence</keyword>
	<keyword>Nicotine</keyword>
	<keyword>Tobacco</keyword>
	<keyword>Transdermal Nicotine Replacement Therapy</keyword>
	<keyword>Functional Magnetic Resonance Imaging</keyword>
	<keyword>Neuroimaging</keyword>
	<keyword>Cue Reactivity</keyword>
	<keyword>Resting State</keyword>
	<keyword>BOLD fMRI</keyword>
</DOC>